PL2379557T3 - Związek aminopirazolowy - Google Patents

Związek aminopirazolowy

Info

Publication number
PL2379557T3
PL2379557T3 PL09795842T PL09795842T PL2379557T3 PL 2379557 T3 PL2379557 T3 PL 2379557T3 PL 09795842 T PL09795842 T PL 09795842T PL 09795842 T PL09795842 T PL 09795842T PL 2379557 T3 PL2379557 T3 PL 2379557T3
Authority
PL
Poland
Prior art keywords
pyrazole compound
amino pyrazole
amino
compound
pyrazole
Prior art date
Application number
PL09795842T
Other languages
English (en)
Polish (pl)
Inventor
Timothy Paul Burkholder
Joshua Ryan Clayton
Liandong Ma
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41630090&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2379557(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL2379557T3 publication Critical patent/PL2379557T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL09795842T 2008-12-16 2009-12-08 Związek aminopirazolowy PL2379557T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12285408P 2008-12-16 2008-12-16
PCT/US2009/067056 WO2010074947A1 (en) 2008-12-16 2009-12-08 Amino pyrazole compound
EP09795842A EP2379557B1 (en) 2008-12-16 2009-12-08 Amino pyrazole compound

Publications (1)

Publication Number Publication Date
PL2379557T3 true PL2379557T3 (pl) 2013-03-29

Family

ID=41630090

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09795842T PL2379557T3 (pl) 2008-12-16 2009-12-08 Związek aminopirazolowy

Country Status (38)

Country Link
US (2) US7897600B2 (https=)
EP (1) EP2379557B1 (https=)
JP (1) JP5509217B2 (https=)
KR (1) KR101300458B1 (https=)
CN (1) CN102232075B (https=)
AR (1) AR074240A1 (https=)
AU (1) AU2009330503B2 (https=)
BR (1) BRPI0923048A2 (https=)
CA (1) CA2744714C (https=)
CL (1) CL2011001445A1 (https=)
CO (1) CO6331442A2 (https=)
CR (1) CR20110341A (https=)
CY (1) CY1113637T1 (https=)
DK (1) DK2379557T3 (https=)
DO (1) DOP2011000190A (https=)
EA (1) EA019554B1 (https=)
EC (1) ECSP11011132A (https=)
ES (1) ES2396617T3 (https=)
HN (1) HN2011001697A (https=)
HR (1) HRP20120918T1 (https=)
IL (1) IL213065A0 (https=)
JO (1) JO2833B1 (https=)
MA (1) MA32900B1 (https=)
MX (1) MX2011006441A (https=)
MY (1) MY158691A (https=)
NZ (1) NZ592641A (https=)
PA (1) PA8851101A1 (https=)
PE (1) PE20110549A1 (https=)
PL (1) PL2379557T3 (https=)
PT (1) PT2379557E (https=)
SG (1) SG172202A1 (https=)
SI (1) SI2379557T1 (https=)
SV (1) SV2011003949A (https=)
TN (1) TN2011000292A1 (https=)
TW (1) TWI440640B (https=)
UA (1) UA104743C2 (https=)
WO (1) WO2010074947A1 (https=)
ZA (1) ZA201103942B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8105633B2 (en) * 2006-03-01 2012-01-31 Spintec Engineering Gmbh Method and apparatus for extraction of arthropod gland
GB2435646A (en) * 2006-03-01 2007-09-05 Spin Tec Engineering Gmbh Apparatus and method of extraction of an arthropod gland
US20110121485A1 (en) * 2006-10-30 2011-05-26 Spintec Engineering Gmbh Method and apparatus for the manufacture of a fiber
CN103458970A (zh) * 2011-03-07 2013-12-18 泰莱托恩基金会 Tfeb磷酸化抑制剂及其应用
US9573960B2 (en) * 2011-06-15 2017-02-21 Life & Brain Gmbh Glioblastoma inhibiting compounds and their use
JP6280546B2 (ja) 2012-06-26 2018-02-14 デル マー ファーマシューティカルズ ジアンヒドロガラクチトール、ジアセチルジアンヒドロガラクチトール、ジブロモズルシトール、又はこれらの類似体若しくは誘導体を用いた、遺伝子多型又はａｈｉ１の調節不全若しくは変異を有する患者におけるチロシンキナーゼインヒビター抵抗性悪性腫瘍を処置するための方法
PL400213A1 (pl) 2012-08-01 2014-02-03 Celon Pharma Spólka Z Ograniczona Odpowiedzialnoscia Pochodne imidazo[1,2-b]pirydazyno-6-aminy jako inhibitory kinazy JAK-2
AR101504A1 (es) 2014-08-11 2016-12-21 Acerta Pharma Bv Combinaciones terapéuticas de un inhibidor de la btk, un inhibidor de la pi3k, un inhibidor de la jak-2, y/o un inhibidor de la cdk4/6
PL3179991T3 (pl) 2014-08-11 2022-02-14 Acerta Pharma B.V. Kombinacje terapeutyczne inhibitora btk i inhibitora bcl-2
TW201618775A (zh) 2014-08-11 2016-06-01 艾森塔製藥公司 Ｂｔｋ抑制劑、ｐｉ３ｋ抑制劑、ｊａｋ－２抑制劑、ｐｄ－１抑制劑及／或ｐｄ－ｌ１抑制劑之治療組合物
EP3541817B1 (en) * 2016-11-17 2020-12-23 Bristol-Myers Squibb Company Imidazopyridazine modulators of il-12, il-23 and/or ifn-alpha
WO2018167283A1 (en) 2017-03-17 2018-09-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma associated neural remodeling
EP3610264A1 (en) 2017-04-13 2020-02-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma
KR102328682B1 (ko) 2018-08-27 2021-11-18 주식회사 대웅제약 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물
WO2020092015A1 (en) 2018-11-02 2020-05-07 University Of Rochester Therapeutic mitigation of epithelial infection
CN110305140B (zh) 2019-07-30 2020-08-04 上海勋和医药科技有限公司 二氢吡咯并嘧啶类选择性jak2抑制剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989385B2 (en) 2000-12-21 2006-01-24 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
JP2003137785A (ja) * 2001-08-23 2003-05-14 Takeda Chem Ind Ltd Ｊｎｋ活性化阻害剤
PL369856A1 (en) 2001-12-21 2005-05-02 Anormed Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
ES2347172T3 (es) 2005-02-16 2010-10-26 Astrazeneca Ab Compuestos quimicos.
SI1853588T1 (sl) 2005-02-16 2008-10-31 Astrazeneca Ab Kemične spojine
JP5054004B2 (ja) * 2005-07-01 2012-10-24 アイアールエム・リミテッド・ライアビリティ・カンパニー タンパク質キナーゼ阻害剤としてのピリミジン置換ベンゾイミダゾール誘導体
GB0515026D0 (en) * 2005-07-21 2005-08-31 Novartis Ag Organic compounds
CN101321759A (zh) * 2005-10-06 2008-12-10 先灵公司 作为蛋白激酶抑制剂的吡唑并嘧啶化合物
JP5052518B2 (ja) * 2005-10-06 2012-10-17 シェーリング コーポレイション プロテインキナーゼインヒビターとしてのピラゾロピリミジン
KR20080080584A (ko) * 2005-11-30 2008-09-04 버텍스 파마슈티칼스 인코포레이티드 ｃ-Ｍｅｔ의 억제제 및 이의 용도
US7989459B2 (en) * 2006-02-17 2011-08-02 Pharmacopeia, Llc Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
CN101594909A (zh) 2006-09-07 2009-12-02 比奥根艾迪克Ma公司 用于治疗炎性病症、细胞增殖性失调、免疫失调的irak调节剂
JP2010508315A (ja) * 2006-10-30 2010-03-18 ノバルティス アーゲー 抗炎症剤としてのヘテロ環式化合物
JP2010524911A (ja) * 2007-04-18 2010-07-22 アストラゼネカ アクチボラグ ５−アミノピラゾール−３−イル−３Ｈ−イミダゾ［４，５−ｂ］ピリジン誘導体と癌の治療のためのその使用
JP2010527999A (ja) 2007-05-23 2010-08-19 フアーマコペイア・エル・エル・シー ＰＫＣ−θ阻害剤としてのプリノン類および１Ｈ−イミダゾピリジノン類
WO2009062059A2 (en) 2007-11-08 2009-05-14 Pharmacopeia, Inc. Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors

Also Published As

Publication number Publication date
HRP20120918T1 (hr) 2012-12-31
CA2744714A1 (en) 2010-07-01
HK1160109A1 (en) 2012-08-10
MY158691A (en) 2016-10-31
UA104743C2 (ru) 2014-03-11
AU2009330503A1 (en) 2010-07-01
TWI440640B (zh) 2014-06-11
EP2379557B1 (en) 2012-10-31
ZA201103942B (en) 2012-08-29
JO2833B1 (en) 2014-09-15
US20100286139A1 (en) 2010-11-11
TW201024301A (en) 2010-07-01
WO2010074947A1 (en) 2010-07-01
KR20110084993A (ko) 2011-07-26
ES2396617T3 (es) 2013-02-22
KR101300458B1 (ko) 2013-08-30
EA201170831A1 (ru) 2011-12-30
PE20110549A1 (es) 2011-08-04
TN2011000292A1 (en) 2012-12-17
HN2011001697A (es) 2013-11-26
SI2379557T1 (sl) 2013-02-28
CO6331442A2 (es) 2011-10-20
US7897600B2 (en) 2011-03-01
SG172202A1 (en) 2011-07-28
AR074240A1 (es) 2011-01-05
JP5509217B2 (ja) 2014-06-04
MX2011006441A (es) 2011-07-19
CN102232075A (zh) 2011-11-02
JP2012512158A (ja) 2012-05-31
DK2379557T3 (da) 2012-12-17
US20100152181A1 (en) 2010-06-17
MA32900B1 (fr) 2011-12-01
SV2011003949A (es) 2011-07-21
CL2011001445A1 (es) 2011-11-11
ECSP11011132A (es) 2011-07-29
EP2379557A1 (en) 2011-10-26
NZ592641A (en) 2013-01-25
IL213065A0 (en) 2011-07-31
CN102232075B (zh) 2013-12-11
DOP2011000190A (es) 2011-07-31
PA8851101A1 (es) 2010-07-27
CY1113637T1 (el) 2016-06-22
PT2379557E (pt) 2013-01-14
CA2744714C (en) 2013-06-25
BRPI0923048A2 (pt) 2018-09-25
CR20110341A (es) 2011-07-13
AU2009330503B2 (en) 2012-06-07
EA019554B1 (ru) 2014-04-30

Similar Documents

Publication Publication Date Title
ZA201103942B (en) Amino pyrazole compound
ZA201007686B (en) Amide compound
IL210082A0 (en) Pyrazole compounds 436
GEP20135844B (en) Heterocyclic compound
SI1999114T1 (sl) Pirazoli kot 11-beta-hsd-1
EP2166849A4 (en) SUBSTITUTED PYRAZOL COMPOUNDS
IL210226A0 (en) Azole compound
GB0804989D0 (en) Compound
GB0803494D0 (en) Compound
EP2373313A4 (en) SUBSTITUTED PYRAZOL COMPOUNDS
EP2235089A4 (en) POLYAMIDE
IL207035A0 (en) Benzylpiperizine compound
IL215235A0 (en) Pyrazole compound
ZA201102450B (en) Amino acid derivative
EP2345644A4 (en) INDAZOLE COMPOUND
GB0823316D0 (en) Compound
GB0806744D0 (en) Novel pyrazole derivatives
GB0807160D0 (en) Compound
GB0806844D0 (en) Compound
GB0820916D0 (en) Compound
GB0820918D0 (en) Compound
GB0822635D0 (en) Compound
GB0815806D0 (en) Compound
GB0812580D0 (en) Compound
GB0820249D0 (en) Compound